Clinical Trials Browser

Phase 2 × OTHER × DTC - Differentiated Thyroid Cancer × Clear all

NCT05007093 2024-11-07

Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib

Phase 2 Active not recruiting

EndocrineHead & Neck

DTC - Differentiated Thyroid Cancer